Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Hippocampal Temporal Interference Stimulation for Memory and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment

8 de noviembre de 2026 actualizado por: Jiaojiao Lü, PhD, Shanghai University of Sport

Effects and Underlying Mechanisms of Hippocampal-Targeted Temporal Interference Stimulation on Memory Function and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment

This randomized crossover study aims to investigate the immediate effects of hippocampal temporal interference stimulation (TIS) on memory and dual-task postural control in older adults with mild cognitive impairment (MCI).

Participants are assigned to receive three stimulation conditions: 40 Hz TIS, 5 Hz TIS, and sham stimulation. Each condition is administered in a separate session in a randomized order, with at least 7 days between consecutive sessions.

The study compares memory and dual-task postural control across the three stimulation conditions. Memory and dual-task postural control assessments are planned before and after each stimulation session.

Descripción general del estudio

Estado

Reclutamiento

Tipo de estudio

Intervencionista

Inscripción (Estimado)

21

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Jiaojiao Lü, PhD
  • Número de teléfono: +86 18516565889
  • Correo electrónico: ljj27@163.com

Ubicaciones de estudio

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Porcelana, 200438
        • Reclutamiento
        • Shanghai University of Sport
        • Contacto:
          • Ethics Committee of the Shanghai University of Sport
          • Número de teléfono: +86 21 65508179
          • Correo electrónico: lunli@sus.edu.cn

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

65 años y mayores (Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

  1. Age 65 years or older.
  2. Presence of subjective memory complaints.
  3. Objective cognitive impairment, defined as a corrected MoCA-BJ total score of less than 26. The MoCA-BJ has a maximum score of 30. For participants with no more than 12 years of education, 1 point is added to the raw score, and the corrected total score is capped at 30 points.
  4. Global Clinical Dementia Rating (CDR) score of 0.5.
  5. No diagnosis of dementia, with an MMSE score of at least 18 for illiterate participants, at least 21 for those with primary school education, and at least 25 for those with junior high school education or above.
  6. Remains independent in activities of daily living (ADL) and is able to cooperate with all assessments and interventions.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación cruzada
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: 40 Hz Temporal Interference Stimulation

Participants receive one 20-minute session of active 40 Hz temporal interference stimulation (TIS) targeting the left hippocampus. In this randomized crossover study, participants are also assigned to receive 5 Hz TIS and sham stimulation in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the 40 Hz stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Otros nombres:
  • TIs
Comparador falso: sham group

Participants receive one 20-minute session of sham temporal interference stimulation (TIS), using the same electrode placement and setup as the 40 Hz TIS session. In this randomized crossover study, participants are also assigned to receive 40 Hz and 5 Hz TIS in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the sham stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Otros nombres:
  • TIs
Experimental: 5 Hz Temporal Interference Stimulation

Participants receive one session of active 5 Hz temporal interference stimulation (TIS). In this randomized crossover study, participants are also assigned to receive 40 Hz TIS and sham stimulation in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the 5 Hz stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Otros nombres:
  • TIs

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change From Pre-intervention in Object-Scene Associative Memory Retrieval Accuracy After Stimulation
Periodo de tiempo: Immediately before and after each 20-minute stimulation session during each crossover period

Accuracy is assessed using a computerized object-scene associative memory task programmed in E-Prime 3.0. Accuracy is calculated as the number of correct match/non-match responses divided by the total number of valid retrieval trials and multiplied by 100. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Higher accuracy indicates better performance.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Object-Scene Associative Memory Retrieval Reaction Time After Stimulation
Periodo de tiempo: Immediately before and after each 20-minute stimulation session during each crossover period

Reaction time is recorded by E-Prime 3.0 during the object-scene associative memory task. Mean reaction time is calculated using valid trials with correct responses. Trials with no response or reaction times shorter than 300 milliseconds are excluded. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Shorter reaction times indicate faster responses.

Immediately before and after each 20-minute stimulation session during each crossover period

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change From Pre-intervention in Word Recognition Accuracy After Stimulation
Periodo de tiempo: Immediately before and after each 20-minute stimulation session during each crossover period

Accuracy is assessed using a computerized word-recognition task programmed in E-Prime 3.0. Accuracy is calculated as the number of correct responses divided by the total number of analyzed trials and multiplied by 100. The two recognition cycles are analyzed separately. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Higher accuracy indicates better performance.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Word Recognition Reaction Time After Stimulation
Periodo de tiempo: Immediately before and after each 20-minute stimulation session during each crossover period

Reaction time is recorded by E-Prime 3.0 during the word-recognition task. Mean reaction time is calculated using valid trials with correct responses. The two recognition cycles are analyzed separately. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Shorter reaction times indicate faster responses.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Dual-Task Cost of 3-Meter Timed Up and Go Completion Time After Stimulation
Periodo de tiempo: Immediately before and after each 20-minute stimulation session during each crossover period

Participants perform the 3-meter Timed Up and Go test under single-task and dual-task conditions. During the dual-task condition, participants complete the test while continuously subtracting 3 from a randomly selected three-digit number. Total completion time is measured in seconds using the Mobility Lab wearable motion analysis system. Each condition is tested three times, and the mean completion time is used. Dual-task cost is calculated as: [(dual-task completion time - single-task completion time) / single-task completion time] × 100%. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. A higher dual-task cost indicates greater deterioration in mobility performance under cognitive load.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Dual-Task Cost of 7-Meter Walking Speed After Stimulation
Periodo de tiempo: Immediately before and after each 20-minute stimulation session during each crossover period

Participants complete the 7-meter walking test at their usual comfortable speed under single-task and dual-task conditions. During the dual-task condition, participants walk while continuously subtracting 3 from a randomly selected three-digit number. Walking speed is measured in meters per second using the Mobility Lab wearable motion analysis system. Each condition is tested three times, and the mean walking speed is used. Dual-task cost is calculated as: [(single-task walking speed - dual-task walking speed) / single-task walking speed] × 100%. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. A higher dual-task cost indicates a greater reduction in walking speed under cognitive load.

Immediately before and after each 20-minute stimulation session during each crossover period
Number of Participants With Any Stimulation-Associated Adverse Symptom
Periodo de tiempo: During and immediately after each 20-minute stimulation session in each crossover period

Safety is assessed using a standardized adverse-reaction questionnaire completed immediately after each stimulation session. Prespecified symptoms include tingling, itching, burning sensation, pain, skin redness, fatigue, visual sensations, difficulty concentrating, and mood changes. Each symptom is rated as none, mild, moderate, or severe, corresponding to scores of 0, 1, 2, and 3, respectively. Other spontaneously reported symptoms are also recorded. For each stimulation condition, a participant is counted as having an adverse symptom if at least one prespecified or spontaneously reported symptom is present with a severity score of 1 or higher during or immediately after stimulation.

During and immediately after each 20-minute stimulation session in each crossover period

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

30 de julio de 2026

Finalización primaria (Estimado)

15 de julio de 2027

Finalización del estudio (Estimado)

30 de julio de 2027

Fechas de registro del estudio

Enviado por primera vez

8 de agosto de 2026

Primero enviado que cumplió con los criterios de control de calidad

13 de agosto de 2026

Publicado por primera vez (Actual)

18 de agosto de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

12 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

8 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • ID: 102772026RT090

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir